Results 1 to 10 of about 15,990,185 (371)

BLOOM: A 176B-Parameter Open-Access Multilingual Language Model [PDF]

open access: yesarXiv.org, 2022
Large language models (LLMs) have been shown to be able to perform new tasks based on a few demonstrations or natural language instructions. While these capabilities have led to widespread adoption, most LLMs are developed by resource-rich organizations ...
Teven Le Scao   +390 more
semanticscholar   +1 more source

Worldwide open access: UK leadership? [PDF]

open access: yes, 2013
The web is destined to become humankind's cognitive commons, where digital knowledge is jointly created and freely shared. The UK has been a leader in the global movement toward open access (OA) to research but recently its leadership has been derailed ...
Harnad, Stevan
core   +10 more sources

JASPAR 2024: 20th anniversary of the open-access database of transcription factor binding profiles

open access: yesNucleic Acids Research, 2023
JASPAR (https://jaspar.elixir.no/) is a widely-used open-access database presenting manually curated high-quality and non-redundant DNA-binding profiles for transcription factors (TFs) across taxa.
Ieva Rauluseviciute   +19 more
semanticscholar   +1 more source

Peculiarities of Integrating Mechanical Valves in Microfluidic Channels Using Direct Laser Writing

open access: yesApplied Bionics and Biomechanics, 2022
Regenerative medicine is a fast expanding scientific topic. One of the main areas of development directions in this field is the usage of additive manufacturing to fabricate functional components that would be later integrated directly into the human ...
Lucero Hernandez-Cedillo   +9 more
doaj   +1 more source

JASPAR 2022: the 9th release of the open-access database of transcription factor binding profiles

open access: yesNucleic Acids Res., 2021
JASPAR (http://jaspar.genereg.net/) is an open-access database containing manually curated, non-redundant transcription factor (TF) binding profiles for TFs across six taxonomic groups.
J. Castro-Mondragón   +22 more
semanticscholar   +1 more source

Understanding what matters to metastatic castration‐resistant prostate cancer (mCRPC) patients when considering treatment options: A US patient preference survey

open access: yesCancer Medicine, 2023
Background Understanding how patients perceive the efficacy, safety, and administrative burden of treatments for metastatic castration‐resistant prostate cancer (mCRPC) can facilitate shared‐decision making for optimal management.
Daniel J. George   +6 more
doaj   +1 more source

An open-access database and analysis tool for perovskite solar cells based on the FAIR data principles

open access: yesNature Energy, 2021
Large datasets are now ubiquitous as technology enables higher-throughput experiments, but rarely can a research field truly benefit from the research data generated due to inconsistent formatting, undocumented storage or improper dissemination.
T. Jacobsson   +93 more
semanticscholar   +1 more source

Perceived facilitators and predictors of positive change and posttraumatic growth following a first episode of psychosis: a mixed methods study using a convergent design

open access: yesBMC Psychiatry, 2020
Background This study aimed to identify predictors and perceived facilitators of positive change and posttraumatic growth in persons with a first episode of psychosis using a mixed methods convergent design.
Gerald Jordan   +2 more
doaj   +1 more source

A review of center of pressure (COP) variables to quantify standing balance in elderly people: Algorithms and open‐access code

open access: yesPhysiological Reports, 2021
Postural control is often quantified by recording the trajectory of the center of pressure (COP)—also called stabilogram—during human quiet standing. This quantification has many important applications, such as the early detection of balance degradation ...
F. Quijoux   +11 more
semanticscholar   +1 more source

Cost-effectiveness analysis of abemaciclib with endocrine therapy (ET) versus ET alone for HR+, HER2−, node-positive, high-risk early breast cancer in Italy

open access: yesGlobal & Regional Health Technology Assessment, 2023
Background: Abemaciclib was recently approved by the European Medicines Agency in combination with adjuvant endocrine therapy (ET) for adult patients with hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2−), node ...
Alison Davie   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy